GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cyfuse Biomedical KK (TSE:4892) » Definitions » Debt-to-Revenue

Cyfuse Biomedical KK (TSE:4892) Debt-to-Revenue : N/A (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Cyfuse Biomedical KK Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Cyfuse Biomedical KK's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was 円525.80 Mil. Cyfuse Biomedical KK's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was 円327.00 Mil. Cyfuse Biomedical KK's annualized Revenue for the quarter that ended in Dec. 2024 was 円0.00 Mil.


Cyfuse Biomedical KK Debt-to-Revenue Historical Data

The historical data trend for Cyfuse Biomedical KK's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyfuse Biomedical KK Debt-to-Revenue Chart

Cyfuse Biomedical KK Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Revenue
3.85 0.80 2.43 14.94 15.66

Cyfuse Biomedical KK Quarterly Data
Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.89 7.27 18.81 27.55 N/A

Competitive Comparison of Cyfuse Biomedical KK's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Cyfuse Biomedical KK's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cyfuse Biomedical KK's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cyfuse Biomedical KK's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cyfuse Biomedical KK's Debt-to-Revenue falls into.


;
;

Cyfuse Biomedical KK Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Cyfuse Biomedical KK's Debt-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(525.8 + 327) / 54.446
=15.66

Cyfuse Biomedical KK's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(525.8 + 327) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2024) Revenue data.


Cyfuse Biomedical KK Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cyfuse Biomedical KK's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Cyfuse Biomedical KK Business Description

Traded in Other Exchanges
N/A
Address
3-5-27, Mita, West Wing-1st Floor. Sumitomo Fudosan Mita Twin Building, Minato-ku, Tokyo, JPN
Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine related products.

Cyfuse Biomedical KK Headlines

No Headlines